Literature DB >> 9585896

Capillaropathy and capillaroneogenesis in the pathogenesis of rosacea.

E Neumann1, A Frithz.   

Abstract

BACKGROUND: Dilatation of vascular vessels in rosacea has generally been attributed to yielding to deranged connective tissue. In contrast, in a previous study a degrading effect of insufficient vascular vessels in connective tissue has been demonstrated in connection with diabetic microangiopathy. In yet another paper, it was demonstrated that the fusing of damaged capillaries, which had lost part of their adjacent walls due to functional inadequacy, led to the formation of dilated vessels. These pathogenetic patterns are the main subjects of this study of rosacea.
METHODS: Punch biopsies from rosacea lesions were examined by light microscopy and immunochemistry in order to identify structural changes leading to the formation of telangiectasias.
RESULTS: Deranged connective tissue is secondary to damaged capillaries. The primary damage may be evoked mostly by environmental influences, mainly the sun.
CONCLUSIONS: Infections, infestations, and granulomatous formations are not primary in the development of rosacea.

Entities:  

Mesh:

Year:  1998        PMID: 9585896     DOI: 10.1046/j.1365-4362.1998.00275.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.

Authors:  Ugur Ozerdem; William B Stallcup
Journal:  Angiogenesis       Date:  2004       Impact factor: 9.596

2.  Novel photopneumatic therapy for the treatment of rosacea.

Authors:  Jun Hyung Kim; Seung Ho Chang; Mi Kyung Cho; Bang Soon Kim
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

3.  Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

4.  Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

Review 5.  Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features.

Authors:  Giuseppe Micali; Peter Arne Gerber; Francesco Lacarrubba; Gregor Schäfer
Journal:  J Clin Aesthet Dermatol       Date:  2016-07-01

6.  Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.

Authors:  Ji Young Kim; Yoon Jee Kim; Beom Jin Lim; Hyo Jung Sohn; Dongyun Shin; Sang Ho Oh
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

7.  Tolerability and safety of GS-101 eye drops, an antisense oligonucleotide to insulin receptor substrate-1: a 'first in man' phase I investigation.

Authors:  Hermann Kain; David Goldblum; Bernard Geudelin; Eric Thorin; Christoph Beglinger
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

8.  Assessment of Tachykinin Receptor 3' Gene Polymorphism rs3733631 in Rosacea.

Authors:  Anthony Karpouzis; Paschalis Avgeridis; Gregory Tripsianis; Elisavet Gatzidou; Niki Kourmouli; Stavroula Veletza
Journal:  Int Sch Res Notices       Date:  2015-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.